CORREVIO PHARMA CORP Chart calendar Correvio Pharma Corp
f.QBij_YdTncgg1WkPcUcbSFJ9SgnEETEb4udOktSFjmE.Om3K0N5kwqt6ugNpAxVOEBQlG1GRQUkjhL8iqpPp1zA4efeI6hHuoVOxXQ~bad8c16bddaabc2491d8c557703a42d6
Upcoming events on Correvio Pharma Corp
No events available
Past events on Correvio Pharma Corp
| 29/06/2020 | Q1 2020 Earnings Release |
| 15/05/2020 10:30 pm | Annual General Meeting |
| 30/03/2020 04:30 pm | FY 2019 Earnings Release |
| 03/12/2019 11:20 pm | Piper Jaffray Healthcare Conference |
| 18/11/2019 10:00 pm | American Heart Association Scientific Meeting - Poster #2028 |
| 14/11/2019 07:00 pm | Q3 2019 Earnings Call |
| 14/11/2019 05:30 pm | Q3 2019 Earnings Release |
| 04/10/2019 08:10 pm | Cantor Global Health Care Conference |
| 10/09/2019 11:15 pm | H.C. Wainwright Global Investor Conference |
| 02/09/2019 05:30 pm | European Society of Cardiology Congress |
| 31/08/2019 | European Society of Cardiology Congress |
| 14/08/2019 06:00 pm | Interim 2019 Earnings Call |
| 14/08/2019 04:30 pm | Interim 2019 Earnings Release |
| 18/06/2019 10:00 pm | Annual General Meeting |
| 08/05/2019 06:00 pm | Q1 2019 Earnings Call |
| 08/05/2019 05:30 pm | Q1 2019 Earnings Release |
| 16/04/2019 04:00 pm | European Clinical Microbiology and Infectious Disease Congress - Poster Number: #P2849 |
| 16/04/2019 04:00 pm | European Clinical Microbiology and Infectious Disease Congress - Poster Number: #P2296 |
| 15/04/2019 07:30 pm | European Clinical Microbiology and Infectious Disease Congress - Oral Presentation Number 00920 |
| 15/04/2019 05:00 pm | European Clinical Microbiology and Infectious Disease Congress - Poster Number: #P1865 |
Annual results
| Fiscal Period | December | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,8 23,6 -11.91% | 25,3 24,5 3.07% | 24,0 24,9 -3.48% | 28,7 28,1 2.06% | 32,6 32,8 -0.65% |
|
EBITDA Million USD | Released Forecast Spread | -19,9 -16,7 -18.86% | -11,6 -11,7 1.16% | -19,5 -19,2 -1.36% | -22,2 -24,8 10.49% | -23,5 -23,4 -0.38% |
|
EBIT Million USD | Released Forecast Spread | -22,1 -18,7 -18.26% | -14,6 -13,5 -7.76% | -23,0 -21,0 -9.59% | -26,3 -27,8 5.15% | -27,5 -26,6 -3.36% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,5 -20,4 -19.81% | -19,5 -18,1 -7.65% | -29,4 -27,0 -9.11% | -16,5 -16,1 -2.81% | -35,0 -35,5 1.29% |
|
Net income Million USD | Released Forecast Spread | -24,5 -21,5 -13.88% | -19,6 -18,4 -6.68% | -29,8 -27,1 -10.14% | -16,6 -16,2 -2.37% | -35,2 -34,7 -1.34% |
|
EPS USD | Released Forecast Spread | -1,34 -1,19 -12.84% | -0,78 -0,72 -8.59% | -0,90 -0,84 -7.78% | -0,47 -0,47 -0.43% | -0,79 -0,78 -1.72% |
| Announcement Date | 10/03/16 | 07/03/17 | 13/03/18 | 13/03/19 | 30/03/20 |
More events
